← Back to Search

Behavioural Intervention

Patient Navigator Intervention for Vision Impairment or Blindness (NYCES Trial)

N/A

Waitlist Available

Led By Lisa A. Hark

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals age 21 and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-year

Awards & highlights

NYCES Trial Summary

This trial aims to improve eye health for adults in New York City by addressing disparities in eye care access & outcomes. #EyeHealth #EyeEquity

Who is the study for?

The NYC Eye Study is for adults aged 21+ living independently in certain affordable housing areas. It's aimed at those with eye conditions like blindness, cataract, diabetic retinopathy, and glaucoma. People with terminal illnesses or unable to consent due to dementia cannot participate.Check my eligibility

What is being tested?

This study tests whether using patient navigators can improve eye health compared to usual care without them. Patient navigators are people who help guide patients through the healthcare system to ensure they receive appropriate care.See study design

What are the potential side effects?

Since this trial involves non-medical interventions (patient navigators), there aren't typical medication side effects. However, participants may experience stress or anxiety from additional appointments or changes in their routine.

NYCES Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

NYCES Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to Follow-up Eye Care

NYCES Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Arm 1: Intervention Using Patient NavigatorsActive Control1 Intervention

Consented participants referred to ophthalmology from the 9 developments randomized to the Intervention Arm will receive ongoing support from patient navigators to assist with all aspects of follow-up eye care and ocular surgery at either Harkness Eye Institute or Harlem Hospital, specifically eye exam appointment scheduling and arranging transportation over a 1-year period.

Group II: Arm 2: Usual Care Without Patient NavigatorsPlacebo Group1 Intervention

Consented participants referred from the 5 developments randomized to the Usual Care Arm 2 who are referred to an ophthalmologist for a follow-up eye exam will only be scheduled for their initial appointment at either Harkness Eye Institute or Harlem Hospital. They will not receive enhanced support. Scheduling this initial appointment will allow tracking of adherence. Arm 2 represents a realistic choice available for participants following screening over a 1-year period.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,450,833 Total Patients Enrolled

1 Trials studying Cataract

749 Patients Enrolled for Cataract

Lisa A. HarkPrincipal InvestigatorColumbia University Department of Ophthalmology

Media Library

Intervention Using Patient Navigators (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05992415 — N/A

Cataract Research Study Groups: Arm 1: Intervention Using Patient Navigators, Arm 2: Usual Care Without Patient Navigators

Cataract Clinical Trial 2023: Intervention Using Patient Navigators Highlights & Side Effects. Trial Name: NCT05992415 — N/A

Intervention Using Patient Navigators (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05992415 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for participants to join this trial currently?

"Per the information on clinicaltrials.gov, this trial has concluded its recruitment process. The study first appeared on July 1st 2024 and was last modified August 7th 2023; however, there are currently 371 other studies seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

New York City Eye Study (NYCES)

Lisa Hark, PhD, MBA 2024. "New York City Eye Study (NYCES)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05992415.

All > Diabetic Retinopathy > Cataract